Irish Medicines Database · HPRA register

Prevenar 20 suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)

Authorisation EU/1/21/1612/001-006 · Pfizer Europe MA EEIG

Licence EU/1/21/1612/001-006 · Unknown

Licence holder: Pfizer Europe MA EEIG (all products →)
Active substances: Pneumococcal polysaccharide serotype 1, Pneumococcal Polysaccharide Serotype 3, Pneumococcal polysaccharide serotype 4, Pneumococcal polysaccharide serotype 5, Pneumococcal Polysaccharide Serotype 6A, Pneumococcal polysaccharide serotype 7f, Pneumococcal Polysaccharide Serotype 8, Pneumococcal polysaccharide serotype 9v, Pneumococcal Polysaccharide Serotype 10A, Pneumococcal Polysaccharide Serotype 11A, Pneumococcal Polysaccharide Serotype 12F, Pneumococcal polysaccharide serotype 14, Pneumococcal Polysaccharide Serotype 15B, Pneumococcal polysaccharide serotype 18c, Pneumococcal Polysaccharide Serotype 19A, Pneumococcal polysaccharide serotype 19f, Pneumococcal Polysaccharide Serotype 22F, Pneumococcal polysaccharide serotype 23f, Pneumococcal Polysaccharide Serotype 33F
Dosage form: Suspension for injection
Route of administration: Intramuscular use
ATC code: J07AL02
First authorised: 14/02/2022
Prescription status: Product subject to prescription which may not be renewed (A)
Supply: Supply through pharmacies only
Legal basis: Full application (Article 8(3) of Directive No 2001/83/EC)

Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.